Tetanus antitoxin seroprevalence in patients with Behçet's disease.
Anti-tetanus antibody status was evaluated by enzyme-linked immunosorbent assay in 82 patients with Behçet's disease and 79 healthy individuals. 76 patients with Behçet's disease (92.7%) and 74 healthy controls (93.7%) had protective antibody titres against tetanus, with geometric mean levels of 1.0194 +/- 1.2755 and 1.3899 +/- 1.6533 IU/ml, respectively. The difference between the 2 groups was not statistically significant. There was a significant inverse correlation between antitoxin titres and age in patient and control groups. These findings imply that patients with Behçet's disease have intact overall immunity against tetanus.
Ayaslioglu
Ergin
E
Department of Infectious Diseases and Clinical Microbiology, Kirikkale University Faculty of Medicine, Kirikkale, Turkey.
Erkek
Emel
E
Kiliç
Dilek
D
Kaygusuz
Sedat
S
Karaca
Fatma
F
Düzgün
Nursen
N
D000293:Adolescent; D000328:Adult; D001528:Behcet Syndrome / Q000175:diagnosis / Q000276:immunology*; D016022:Case-Control Studies; D015331:Cohort Studies; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011336:Probability; D012016:Reference Values; D012680:Sensitivity and Specificity; D016036:Seroepidemiologic Studies; D013742:Tetanus / Q000517:prevention & control*; D013743:Tetanus Antitoxin / Q000276:immunology*
D013743:Tetanus Antitoxin